CD33 and Alzheimer disease: Based on a CD33-null allele (rs201074739) lacking any AD-protective effects [14, 84], the loss-of-function alone may be insufficient to produce an AD-protective effect, suggesting the gain-of-function role is at play for beneficial effects of rs12459419T.